One of the most important things you can do when choosing a doctor is make sure that you feel that person has your best interests in mind.
Throughout our website we provide information regarding every aspect of the hair transplant process. From what to expect during your consultation and what questions to ask, all the way through the recovery process and how long until you see the results of your surgery. But we realize that it may not always be easy to find that information that you’re looking for, regardless of how well the content is organized.
Nothing’s easy about cancer or undergoing chemotherapy. However, as cancer-related research and technology advances, so do remedies developed to combat chemotherapy’s many side effects. One of these most dreaded side effects includes hair loss.
For both men and women, hair loss is one of the most challenging aspects of chemotherapy. Some people report having a harder time coping with hair loss than by losing a body part to cancer or even receiving the cancer diagnosis itself.
In Observation of Prostate Cancer Awareness Week: Cancer and Hair Loss from a Different Angle
About a year ago, we published an entry on the hair blog addressing the question, “Does Cancer Cause Hair Loss?” This week, in observation of National Prostate Health Month (September) and Prostate Cancer Awareness Week (Sept. 17-24), we’re revisiting the connection between cancer and hair loss. But instead of considering cancer as a cause of hair loss (which it usually isn’t), we’re investigating hair loss as a possible indicator of a specific type of cancer—prostate.
With this week’s hair blog, we report on yet another accidental discovery recently made in the world of hair loss research. Researchers at the University of California San Francisco have discovered that a specialized type of immune cell normally associated with inflammation also plays a vital role in stimulating stem cells within the skin to promote hair-follicle regrowth.
We start today’s hair blog with a strange question: What is Neurofibromatosis? Neurofibromatosis Type 1 is a rare hereditary disease that causes multiple noncancerous (benign) tumors of nerves and skin (neurofibromas) patches of abnormal skin color (birth marks) but may also cause tumors in the brain, eyes, breast, bones etc. Now you might be wondering, “What does research into Neurofibromatosis have to do with balding and hair loss research in general?” Good question.
According to a recent study published in the Journal PLOS Genetics and reported by WebMD, a group of researchers in Scotland have successfully found 287 genetic “coding regions” linked to severe hair loss in men. Researchers performed genetic analysis of 52,000 subjects, ages 40-69, making this the largest study of its type to date.